NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Christopher J. Pazoles, Ph.D., Vice President of R&D of Novelos, will present at the 2007 Hollings Cancer Center Spring Symposium entitled “Cancer Drug Discovery and Development: Bridging Academic and Industry Partnerships” on March 23-24, 2007 in Kiawah Island, SC. The symposium, organized by the Medical University of South Carolina (MUSC), will focus on the science, clinical testing and business aspects underlying the development of novel cancer therapeutics.
